AI product management · Industry brief

Medical AI is escaping regulatory classification by design.

Adjunct AI medical products (AMPs)—AI tools that advise clinicians without directly controlling devices—fall through EU oversight cracks between the 2024 AI Act and sector-specific medical device regulations [Quelle: NIH PMC]. Vendors exploit these gaps by redesigning products to avoid medical device classification entirely. The Commission is expected to close these loopholes by Q1 2027, reshaping product strategy for vendors selling into European healthcare markets and forcing retroactive compliance work on existing deployments.

Expect enforcement actions on misclassified products within six months of the regulatory fix.

Enterprise buyers now demand governance baked into core product, not retrofit later.

Following the hiring surge we tracked earlier this week, Box, Google, Schwab, and Humana are aggressively recruiting product managers focused on AI compliance infrastructure, trust controls, and data governance [Quelle: Enterprise Careers]. When hyperscalers like Google reorganize entire PM teams around trust and controls—anchoring governance in core product layers rather than compliance silos—enterprise vendors follow within quarters. Deals above $2M now require governance visibility as table stakes.

Product teams moving governance into day-one roadmaps will own the enterprise AI stack through 2027.